Excerpt:
"A new peer-reviewed cancer protocol authored by a team of sixteen cancer doctors and medical researchers from the US and several other nations was published in the September 2024 Journal of Orthomolecular Medicine, titled “Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol.” Its authors were prominent in oncology, and the published protocol was heavily footnoted to 204 medical studies documenting in vivo and in vitro safe and successful use of each and every element of the protocol. The authors of many of the referenced studies are at the top of their profession, i.e., well-known, highly published doctors and medical research professionals.
...
From the research presented in the paper, a hybrid orthomolecular protocol was developed that relies upon six elements (or “molecules”):

[1] a therapeutic ketogenic diet high in fats and protein but low in carbs.

[2] moderate exercise (aerobic heart rate) for 45-75 minutes three times a week, such as cycling, running, swimming, etc.

[3] high-dose (non-toxic level) vitamin C by IV, PICC, or port three times a week.

[4] ivermectin daily at a proven safe dosage.

[5] fenbendazole (or mebendazole) daily at a proven safe dosage.

[6] daily vitamin/mineral supplements of safe levels of vitamin D, vitamin K2, zinc, magnesium, and potassium, with a lab test every two weeks to monitor liver and kidney function and potassium and vitamin D levels for safety.."